MedinCell S.A. (MDCLF) Discusses U.S. Approval of Weltruza and Its Impact on Schizophrenia Treatment and Financial Outlook Transcript
…
26,260€
1,47%
Echtzeit-Aktienkurs MEDINCELL S.A. EO-,01
Bid:
Ask:
Nachrichten zur MEDINCELL S.A. EO-,01 Aktie
Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed
Medincell shares dive 15% as FY26 loss widens, AbbVie trial delayed…
Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
…